Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

1cP-LSD

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
1cP-LSD
Clinical data
Other names1-CPA-LSD; 1-cyclopropanoyl-LSD; 1-(Cyclopropylmethanoyl)-LSD; 1cP;
Routes of
administration
Oral
Drug classSerotonergic psychedelic;Hallucinogen
Legal status
Legal status
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4-cyclopropylmethanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChemCID
ChemSpider
UNII
Chemical and physical data
FormulaC24H29N3O2
Molar mass391.515 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@@H]5C=C2[C@@H](Cc3cn(C(=O)C1CC1)c4cccc2c34)N(C)C5
  • InChI=1S/C24H29N3O2/c1-4-26(5-2)23(28)17-11-19-18-7-6-8-20-22(18)16(12-21(19)25(3)13-17)14-27(20)24(29)15-9-10-15/h6-8,11,14-15,17,21H,4-5,9-10,12-13H2,1-3H3/t17-,21-/m1/s1
  • Key:RAFUPYYDHPFASC-DYESRHJHSA-N

1cP-LSD, or1-CPA-LSD, also known as1-cyclopropanoyl-LSD, is apsychedelic drug of thelysergamide family and anacylatedderivative oflysergic acid diethylamide (LSD) which has been sold as adesigner drug.[1][2][3] It is aprodrug of LSD.[1]

Use and effects

[edit]
See also:LSD § Uses, andLSD § Effects

1cP-LSD has been used in the form ofblotter tabs containing 100 μg 1cP-LSDfree base andpellets containing 150 μg 1cP-LSDhemitartrate.[1]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

1cP-LSD is aprodrug ofLSD.[1] It has been found to producepsychedelic-like effects, specifically thehead-twitch response, in rodents with similarpotency as1P-LSD.[1]

Chemistry

[edit]

Analogues

[edit]

Related compounds include1B-LSD,1DD-LSD,1P-LSD,1V-LSD,ALD-52 (1A-LSD),1cP-AL-LAD,AL-LAD,ETH-LAD,1P-ETH-LAD,PRO-LAD,LSM-775, andLSZ, among others.

History

[edit]

1cP-LSD was firstsynthesized as a legal LSD alternative byLizard Labs, aNetherlands basedresearch chemical laboratory.[citation needed]

Society and culture

[edit]

Legal status

[edit]
1cP-LSD on blotter paper.

Sweden

[edit]

Sweden's public health agency suggested classifying 1cP-LSD as adangerous substance on 18 December 2019 and later classified it as such on 22 April 2021.[4][5]

Research

[edit]

1cP-LSD has been investigated as a potential treatment foranxiety in dogs.[6][7]

See also

[edit]

References

[edit]
  1. ^abcdeBrandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, et al. (June 2020)."Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)".Drug Testing and Analysis.12 (6):812–826.doi:10.1002/dta.2789.PMC 9191646.PMID 32180350.
  2. ^Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R (2020)."[Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet]".Yakugaku Zasshi.140 (11):1405–1413.doi:10.1248/yakushi.20-00124.PMID 33132277.
  3. ^Vincenti F, Gregori A, Flammini M, Di Rosa F, Salomone A (September 2021)."Seizures of New Psychoactive Substances on the Italian territory during the COVID-19 pandemic".Forensic Science International.326 110904.doi:10.1016/j.forsciint.2021.110904.PMC 8411784.PMID 34371393.
  4. ^"Förordning (1999:58) om förbud mot vissa hälsofarliga varor".
  5. ^"Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara" [Twenty-three substances are proposed to be classified as drugs or dangerous goods] (in Swedish). Folkhälsomyndigheten. December 18, 2019. Archived fromthe original on November 24, 2022. RetrievedMay 28, 2020.
  6. ^Hernández-Álvarez E, Borkel LF, Rojas-Hernández J, Quintana-Hernández DJ, García-Serrano I, Fernández-Borkel T, et al. (July 2025)."Evaluating the Potential of Microdosing 1cp-LSD for the Treatment of Canine Anxiety: A One-Month Case Study".Veterinary Medicine and Science.11 (4) e70486.doi:10.1002/vms3.70486.PMC 12244264.PMID 40638522.
  7. ^Hernández-Álvarez E, Rojas-Hernández J, Borkel LF, Quintana-Hernández DJ, Fernández-Borkel T, Henríquez-Hernández LA (September 2025)."Preliminary Findings on Low-Dose 1cp-LSD for Canine Anxiety: Exploring the Role of Owner Neuroticism and Psychopathology".Veterinary Sciences.12 (9): 872.doi:10.3390/vetsci12090872.PMC 12474181.PMID 41012797.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Ergolines
(incl.lysergines)
Clavines
(6,8-dimethylergolines)
Lysergamides
(lysergic acid amides)
Ergopeptines
(peptide ergolines)
Partial ergolines
Related compounds
Natural sources
Retrieved from "https://en.wikipedia.org/w/index.php?title=1cP-LSD&oldid=1321062097"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp